LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.29 | 84.90 | 1198 | 766 | 1.5622 | 1.3017 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.99 | 84.90 | 29 | 898 | 0.0323 | -0.2706 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.99 | 84.90 | 1088 | 898 | 1.2103 | 1.1153 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.99 | 84.90 | 851 | 898 | 0.9466 | 0.9680 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.99 | 84.90 | 1245 | 898 | 1.3849 | 1.2007 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 19.69 | 84.90 | 46 | 1239 | 0.0371 | -0.1465 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 19.69 | 84.90 | 1146 | 1239 | 0.9246 | 0.9599 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 19.69 | 84.90 | 1149 | 1239 | 0.9270 | 0.9612 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 19.69 | 84.90 | 1312 | 1239 | 1.0586 | 1.0296 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.40 | 84.90 | 58 | 1454 | 0.0399 | -0.0888 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.40 | 84.90 | 1195 | 1454 | 0.8215 | 0.9063 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.40 | 84.90 | 1236 | 1454 | 0.8497 | 0.9221 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.40 | 84.90 | 1354 | 1454 | 0.9308 | 0.9653 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.10 | 84.90 | 83 | 1616 | 0.0514 | -0.0053 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.10 | 84.90 | 1263 | 1616 | 0.7815 | 0.8873 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.10 | 84.90 | 1327 | 1616 | 0.8211 | 0.9094 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.10 | 84.90 | 1423 | 1616 | 0.8805 | 0.9410 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.81 | 84.90 | 89 | 1769 | 0.0503 | 0.0108 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.81 | 84.90 | 1333 | 1769 | 0.7533 | 0.8748 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.81 | 84.90 | 1362 | 1769 | 0.7697 | 0.8840 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.81 | 84.90 | 1495 | 1769 | 0.8449 | 0.9245 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.51 | 84.90 | 88 | 1923 | 0.0458 | 0.0080 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.51 | 84.90 | 1400 | 1923 | 0.7280 | 0.8638 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.51 | 84.90 | 1479 | 1923 | 0.7690 | 0.8867 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.51 | 84.90 | 1576 | 1923 | 0.8195 | 0.9135 | MN20160318_Q02 | N04 |